Hisamitsu Pharmaceutical Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$149.91 | $174.55 | 13.40% | 3 | $360.79B |
| NOVN | Novartis | Hold |
10
|
CHF92.32 | CHF105.00 | 16.57% | 9 | CHF188.37B |
| SAN | Sanofi | Outperform |
16
|
94.33€ | 102.80€ | 15.55% | 9 | 117.78€B |
| MMM | 3M | Hold |
10
|
$98.93 | $109.39 | 4.62% | 3 | $54.74B |
| RKT | Reckitt Benckiser Group | Outperform |
12
|
£45.97 | £66.68 | 17.47% | 12 | £32.35B |
| BAYN | Bayer | Hold |
5
|
28.96€ | 45.15€ | 3.59% | 4 | 28.45€B |
| VTRS | Viatris Inc | Hold |
8
|
$11.16 | $11.73 | 7.53% | 5 | $13.32B |
| H02 | Haw Par Corporation | - |
16
|
$9.65 | $17.00 | -100.00% | 0 | $2.14B |